Alopecia areata and the gut—the link opens up for novel therapeutic interventions

Expert Opinion on Therapeutic Targets

Volumn 22, Issue 6, 2018, Pages 503-511

  Borde, Annika ^a   Åstrand, Annika ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Alopecia areata; autoimmunity; chronic inflammation; intestinal permeability

Indexed keywords

G PROTEIN COUPLED RECEPTOR;

ALOPECIA AREATA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL OVERGROWTH; DIET; ENTERITIS; GENETIC SUSCEPTIBILITY; HAIR FOLLICLE; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENCE; IMMUNOCOMPETENT CELL; INTESTINE FLORA; INTESTINE FUNCTION; INTESTINE MUCOSA PERMEABILITY; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; SMALL INTESTINAL BACTERIAL OVERGROWTH; STOMACH ACID SECRETION; ANIMAL; COMPLICATION; GASTROINTESTINAL DISEASE; IMMUNOLOGY; INFLAMMATION; LIFESTYLE; PATHOLOGY; T LYMPHOCYTE;

ALOPECIA AREATA; ANIMALS; AUTOIMMUNITY; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; HAIR FOLLICLE; HUMANS; INFLAMMATION; LIFE STYLE; T-LYMPHOCYTES;

EID: 85048565726     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1080/14728222.2018.1481504     Document Type: Review

References (105)

1. McKay DM., The therapeutic helminth? Trends Parasitol. 2009 Mar;25(3):109–114. PubMed PMID: 19167926.
2. Cooper GS, Bynum ML, Somers EC., Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009 Nov–Dec;33(3–4):197–207. PubMed PMID: 19819109; PubMed Central PMCID: PMCPMC2783422.
3. Invernizzi P, Gershwin ME. The genetics of human autoimmune disease. J Autoimmun. 2009 Nov–Dec;33(3–4):290–299. PubMed PMID: 19682858.
4. Visser J, Rozing J, Sapone A, et al. Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci. 2009 May;1165:195–205. PubMed PMID: 19538307; PubMed Central PMCID: PMCPMC2886850.
5. Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol. 2009 Jul;124(1):3–20. PubMed PMID: 19560575; PubMed Central PMCID: PMCPMC4266989.
6. Lerner A, Matthias T. Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun Rev. 2015 Jun;14(6):479–489. PubMed PMID: 25676324.
7. Citi S. Intestinal barriers protect against disease. Science. 2018 Mar 9;359(6380):1097–1098. PubMed PMID: 29590026.
8. Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol. 2005 Sep;2(9):416–422. PubMed PMID: 16265432.
9. Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut. 2006 Oct;55(10):1512–1520. PubMed PMID: 16966705; PubMed Central PMCID: PMCPMC1856434.
10. Öhman L, Törnblom H, Simrén M. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS. Nat Rev Gastroenterol Hepatol. 2015 Jan;12(1):36–49. PubMed PMID: 25446728.
11. Marson A, Housley WJ, Hafler DA. Genetic basis of autoimmunity. J Clin Invest. 2015 Jun;125(6):2234–2241. PubMed PMID: 26030227; PubMed Central PMCID: PMCPMC4497748.
12. Lerner A, Jeremias P, Matthias T. The world incidence and prevalence of autoimmune diseases is increasing. Int J Celiac Dis. 2016;3(4):151–155.
13. Abhishek A, Doherty M, Kuo CF, et al. Rheumatoid arthritis is getting less frequent-results of a nationwide population-based cohort study. Rheumatology (Oxford). 2017 May 1;56(5):736–744. PubMed PMID: 28064207.
14. Konturek PC, Brzozowski T, Konturek SJ. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol. 2011 Dec;62(6):591–599. PubMed PMID: 22314561.
15. Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? Nat Rev Immunol. 2010 Oct;10(10):735–744. PubMed PMID: 20865020.
16. Jethwa H, Abraham S. The evidence for microbiome manipulation in inflammatory arthritis. Rheumatology (Oxford). 2017 Sep 1;56(9):1452–1460. PubMed PMID: 27789760.
17. Riordan SM, McIver CJ, Thomas DH, et al. Luminal bacteria and small-intestinal permeability. Scand J Gastroenterol. 1997 Jun;32(6):556–563. PubMed PMID: 9200287.
18. Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010 Jun 28;16(24):2978–2990. PubMed PMID: 20572300; PubMed Central PMCID: PMCPMC2890937.
19. King CE, Toskes PP. Small intestine bacterial overgrowth. Gastroenterology. 1979 May;76(5 Pt 1):1035–1055. PubMed PMID: 437407.
20. McCracken S. The SIBO solution: your comprehensive guide to eliminating small intestinal bacterial overgrowth. Hollywood Homestead, USA; 2015.
21. Catalioto RM, Maggi CA, Giuliani S. Intestinal epithelial barrier dysfunction in disease and possible therapeutical interventions. Curr Med Chem. 2011;18(3):398–426. PubMed PMID: 21143118.
22. Stojanovich L, Marisavljevich D. Stress as a trigger of autoimmune disease. Autoimmun Rev. 2008 Jan;7(3):209–213. PubMed PMID: 18190880.
23. Stojanovich L. Stress and autoimmunity. Autoimmun Rev. 2010 Mar;9(5):A271–6. PubMed PMID: 19931651.
24. Gilhar A, Etzioni A, Paus R. Alopecia areata. N Engl J Med. 2012 Apr 19;366(16):1515–1525. PubMed PMID: 22512484.
25. Wang ECE, Christiano AM. The changing landscape of alopecia areata: the translational landscape. Adv Ther. 2017 Jul;34(7):1586–1593. PubMed PMID: 28646392; PubMed Central PMCID: PMCPMC5504204.
26. Renert-Yuval Y, Guttman-Yassky E. The changing landscape of alopecia areata: the therapeutic paradigm. Adv Ther. 2017 Jul;34(7):1594–1609. PubMed PMID: 28646393; PubMed Central PMCID: PMCPMC5504208.
27. Skurkovich S, Korotky NG, Sharova NM, et al. Treatment of alopecia areata with anti-interferon-gamma antibodies. J Investig Dermatol Symp Proc. 2005 Dec;10(3):283–284. PubMed PMID: 16402484.
28. Lindsey SFTA. Hair loss induced by tumor necrosis factor alpha inhibitors. J Clin Investigat Dermatol. 2013;1(1):1–6.
29. Sobolewska-Wlodarczyk A, Wlodarczyk M, Fichna J, et al. Alopecia areata in patients with inflammatory bowel disease: an overview. Folia Med Cracov. 2016;56(1):5–12. PubMed PMID: 27513834.
30. Kim M, Choi KH, Hwang SW, et al. Inflammatory bowel disease is associated with an increased risk of inflammatory skin diseases: A population-based cross-sectional study. J Am Acad Dermatol. 2017 Jan;76(1):40–48. PubMed PMID: 27793451.
31. Petukhova L, Duvic M, Hordinsky M, et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature. 2010 Jul 1;466(7302):113–117. PubMed PMID: 20596022; PubMed Central PMCID: PMCPMC2921172.
32. Ito T, Tokura Y. The role of cytokines and chemokines in the T-cell-mediated autoimmune process in alopecia areata. Exp Dermatol. 2014 Nov;23(11):787–791. PubMed PMID: 25040075.
33. Meyer KC, Klatte JE, Dinh HV, et al. Evidence that the bulge region is a site of relative immune privilege in human hair follicles. Br J Dermatol. 2008 Nov;159(5):1077–1085. PubMed PMID: 18795933.
34. Ito T, Ito N, Bettermann A, et al. Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol. 2004 Feb;164(2):623–634. PubMed PMID: 14742267; PubMed Central PMCID: PMCPMC1602279.
35. Ito T, Ito N, Saatoff M, et al. Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol. 2008 May;128(5):1196–1206. PubMed PMID: 18160967.
36. Gilhar A. Collapse of immune privilege in alopecia areata: coincidental or substantial? J Invest Dermatol. 2010 Nov;130(11):2535–2537. PubMed PMID: 20944635.
37. Ito T. Hair follicle is a target of stress hormone and autoimmune reactions. J Dermatol Sci. 2010 Nov;60(2):67–73. PubMed PMID: 20943348.
38. Tobin DJ, Manaf S, Sajid H, et al. Evidence for alopecia areata and celiac disease cross-reactive epitopes expressed by anagen hair follicle inner root sheath - implications for alopecia areata autoantigen(s)discovery. Abstract book 9th World Congress for Hair Research, Miami, USA; 2015;Abstract no 156.
39. Erb U, Freyschmidt-Paul P, Zoller M. Tolerance induction by hair-specific keratins in murine alopecia areata. J Leukoc Biol. 2013 Oct;94(4):845–857. PubMed PMID: 23817565.
40. Tobin DJ, Hann SK, Song MS, et al. Hair follicle structures targeted by antibodies in patients with alopecia areata. Arch Dermatol. 1997 Jan;133(1):57–61. PubMed PMID: 9006373.
41. Jabbari A, Petukhova L, Cabral RM, et al. Genetic basis of alopecia areata: a roadmap for translational research. Dermatol Clin. 2013 Jan;31(1):109–117. PubMed PMID: 23159180; PubMed Central PMCID: PMCPMC4362526.
42. Nair L, Dai Z, Christiano AM. 649 Gut microbiota plays a role in the development of alopecia areata. J Invest Dermatol. 2017;137(5):S112.
43. Skogberg G, Jackson S, Astrand A. Mechanisms of tolerance and potential therapeutic interventions in alopecia areata. Pharmacol Ther. 2017 Nov;179:102–110. PubMed PMID: 28546083.
44. Guarneri F. Molecular mimicry in cutaneous autoimmune diseases. World J Dermatol. 2013;2(4). DOI:10.5314/wjd.v2.i4.36
45. Christen U, von Herrath MG. Induction, acceleration or prevention of autoimmunity by molecular mimicry. Mol Immunol. 2004 Feb;40(14–15):1113–1120. PubMed PMID: 15036917.
46. Kranich J, Maslowski KM, Mackay CR. Commensal flora and the regulation of inflammatory and autoimmune responses. Semin Immunol. 2011 Apr;23(2):139–145. PubMed PMID: 21292499.
47. Kalliomaki M, Kirjavainen P, Eerola E, et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol. 2001 Jan;107(1):129–134. PubMed PMID: 11150002.
48. Bjorksten B, Naaber P, Sepp E, et al. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy. 1999 Mar;29(3):342–346. PubMed PMID: 10202341.
49. Panasevich MR, Kerr KR, Dilger RN, et al. Modulation of the faecal microbiome of healthy adult dogs by inclusion of potato fibre in the diet. Br J Nutr. 2015 Jan 14;113(1):125–133. PubMed PMID: 25418803.
50. Bischoff SC, Volynets V. Nutritional influences of overfeeding on experimental outcomes in laboratory mice: consequences for gut microbiota and other functional studies. Int J Med Microbiol. 2016 Aug;306(5):328–333. PubMed PMID: 27432516.
51. Smits SA, Marcobal A, Higginbottom S, et al. Individualized responses of gut microbiota to dietary intervention modeled in humanized mice. mSystems. 2016 Sep–Oct;1(5):e00098–16. PubMed PMID: 27822551; PubMed Central PMCID: PMCPMC5069738.
52. De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14691–14696. PubMed PMID: 20679230; PubMed Central PMCID: PMCPMC2930426.
53. Schnorr SL, Candela M, Rampelli S, et al. Gut microbiome of the Hadza hunter-gatherers. Nat Commun. 2014 Apr 15;5:3654. PubMed PMID: 24736369; PubMed Central PMCID: PMCPMC3996546.
54. Sonnenburg ED, Smits SA, Tikhonov M, et al. Diet-induced extinctions in the gut microbiota compound over generations. Nature. 2016 Jan 14;529(7585):212–215. PubMed PMID: 26762459; PubMed Central PMCID: PMCPMC4850918.
55. Maslowski KM, Mackay CR. Diet, gut microbiota and immune responses. Nat Immunol. 2011 Jan;12(1):5–9. PubMed PMID: 21169997.
56. Maslowski KM. The role of GPR43 in the immune system: a novel connection between diet, gut microbiota and immune function. University of New South Wales, Sydney, Australia; 2013.
57. Sommer F, Backhed F. The gut microbiota–masters of host development and physiology. Nat Rev Microbiol. 2013 Apr;11(4):227–238. PubMed PMID: 23435359.
58. Turnbaugh PJ, Backhed F, Fulton L, et al. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008 Apr 17;3(4):213–223. PubMed PMID: 18407065; PubMed Central PMCID: PMCPMC3687783.
59. Ott SJ, Musfeldt M, Wenderoth DF, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004 May;53(5):685–693. PubMed PMID: 15082587; PubMed Central PMCID: PMCPMC1774050.
60. Nylund L, Satokari R, Nikkila J, et al. Microarray analysis reveals marked intestinal microbiota aberrancy in infants having eczema compared to healthy children in at-risk for atopic disease. BMC Microbiol. 2013 Jan 23;13:12. PubMed PMID: 23339708; PubMed Central PMCID: PMCPMC3563445.
61. Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016 Aug;14(8):e1002533. PubMed PMID: 27541692; PubMed Central PMCID: PMCPMC4991899.
62. Kresser C. Gut Health [ebook]. Available from: https://chriskresser.com/gut-health/
63. Bengmark S. Gut microbiota, immune development and function. Pharmacol Res. 2013 Mar;69(1):87–113. PubMed PMID: 22989504.
64. Human Microbiome Project C. A framework for human microbiome research. Nature. 2012 Jun 13;486(7402):215–221. PubMed PMID: 22699610; PubMed Central PMCID: PMCPMC3377744.
65. Kim CH, Park J, Kim M. Gut microbiota-derived short-chain Fatty acids, T cells, and inflammation. Immune Netw. 2014 Dec;14(6):277–288. PubMed PMID: 25550694; PubMed Central PMCID: PMCPMC4275385.
66. Rojo D, Mendez-Garcia C, Raczkowska BA, et al. Exploring the human microbiome from multiple perspectives: factors altering its composition and function. FEMS Microbiol Rev. 2017 Jul 1;41(4):453–478. PubMed PMID: 28333226.
67. Wu HJ, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes. 2012 Jan–Feb;3(1):4–14. PubMed PMID: 22356853; PubMed Central PMCID: PMCPMC3337124.
68. Abrahamsson TR, Jakobsson HE, Andersson AF, et al. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol. 2012 Feb;129(2):434–2. PubMed PMID: 22153774.
69. Manzel A, Muller DN, Hafler DA, et al. Role of “Western diet” in inflammatory autoimmune diseases. Curr Allergy Asthma Rep. 2014 Jan;14(1):404. PubMed PMID: 24338487; PubMed Central PMCID: PMCPMC4034518.
70. Thorburn AN, Macia L, Mackay CR. Diet, metabolites, and “western-lifestyle” inflammatory diseases. Immunity. 2014 Jun 19;40(6):833–842. PubMed PMID: 24950203.
71. Rabe H. Gut bacteria, regulatory T cells and allergic sensitization in early childhood. Gothenburg University, Gothenburg, Sweden; 2014.
72. Liu AH. Revisiting the hygiene hypothesis for allergy and asthma. J Allergy Clin Immunol. 2015 Oct;136(4):860–865. PubMed PMID: 26449798.
73. Hesselmar B, Hicke-Roberts A, Wennergren G. Allergy in children in hand versus machine dishwashing. Pediatrics. 2015 Mar;135(3):e590–e597. PubMed PMID: 25713281.
74. Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (N Y). 2007 Feb;3(2):112–122. PubMed PMID: 21960820; PubMed Central PMCID: PMCPMC3099351.
75. Lauritano EC, Valenza V, Sparano L, et al. Small intestinal bacterial overgrowth and intestinal permeability. Scand J Gastroenterol. 2010 Sep;45(9):1131–1132. PubMed PMID: 20443749.
76. Choi CH, Chang SK. Role of small intestinal bacterial overgrowth in functional gastrointestinal disorders. J Neurogastroenterol Motil. 2016 Jan 31;22(1):3–5. PubMed PMID: 26717927; PubMed Central PMCID: PMCPMC4699716.
77. Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011 Jan;91(1):151–175. PubMed PMID: 21248165.
78. Flint HJ, Bayer EA, Rincon MT, et al. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol. 2008 Feb;6(2):121–131. PubMed PMID: 18180751.
79. Bolognini D, Tobin AB, Milligan G, et al. The pharmacology and function of receptors for short-chain fatty acids. Mol Pharmacol. 2016 Mar;89(3):388–398. PubMed PMID: 26719580.
80. Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013 Aug 2;341(6145):569–573. PubMed PMID: 23828891; PubMed Central PMCID: PMCPMC3807819.
81. Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013 Dec 19;504(7480):451–455. PubMed PMID: 24226773; PubMed Central PMCID: PMCPMC3869884.
82. Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013 Dec 19;504(7480):446–450. PubMed PMID: 24226770.
83. Bollrath J, Powrie F. Immunology. Feed your Tregs more fiber. Science. 2013 Aug 2;341(6145):463–464. PubMed PMID: 23908210.
84. Correa-Oliveira R, Fachi JL, Vieira A, et al. Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunology. 2016 Apr;5(4):e73. PubMed PMID: 27195116; PubMed Central PMCID: PMCPMC4855267.
85. Sun M, Wu W, Liu Z, et al. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. J Gastroenterol. 2017 Jan;52(1): 1–8. PubMed PMID: 27448578; PubMed Central PMCID: PMCPMC5215992.
86. Ulven T. Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets. Front Endocrinol (Lausanne). 2012;3:111. PubMed PMID: 23060857; PubMed Central PMCID: PMCPMC3462324.
87. Ang Z, Ding JL. GPR41 and GPR43 in obesity and inflammation - protective or causative? Front Immunol. 2016;7:28. PubMed PMID: 26870043; PubMed Central PMCID: PMCPMC4734206.
88. Trompette A, Gollwitzer ES, Yadava K, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014 Feb;20(2):159–166. PubMed PMID: 24390308.
89. Maslowski KM, Vieira AT, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009 Oct 29;461(7268):1282–1286. PubMed PMID: 19865172; PubMed Central PMCID: PMCPMC3256734.
90. Silva KA, Sundberg JP. Surgical methods for full-thickness skin grafts to induce alopecia areata in C3H/HeJ mice. Comp Med. 2013 Oct;63(5):392–397. PubMed PMID: 24210015; PubMed Central PMCID: PMCPMC3796749.
91. McElwee KJ, Boggess D, King LE, Jr., et al. Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol. 1998 Nov;111(5):797–803. PubMed PMID: 9804341.
92. Sundberg JP, Silva KA, Li R, et al. Adult-onset Alopecia areata is a complex polygenic trait in the C3H/HeJ mouse model. J Invest Dermatol. 2004 Aug;123(2):294–297. PubMed PMID: 15245428.
93. Zoller M, McElwee KJ, Engel P, et al. Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata. J Invest Dermatol. 2002 Jun;118(6):983–992. PubMed PMID: 12060392.
94. Annika BM, Åstrand KB, Wingren C, et al., editors. Regulatory T-cells in the C3H/HeJ mouse model of alopecia areata. 9th World Congress on Hair; Miami (FL);2015;Abstract no 007.
95. Sanchez Rodriguez R, Pauli ML, Neuhaus IM, et al. Memory regulatory T cells reside in human skin. J Clin Invest. 2014 Mar;124(3):1027–1036. PubMed PMID: 24509084; PubMed Central PMCID: PMCPMC3934172.
96. Ali N, Zirak B, Rodriguez RS, et al. Regulatory T cells in skin facilitate epithelial stem cell differentiation. Cell. 2017 Jun 1;169(6):1119 e11–1129 e11. PubMed PMID: 28552347; PubMed Central PMCID: PMCPMC5504703.
97. Rebello D, Wang E, Yen E, et al. Hair growth in two alopecia patients after fecal microbiota transplant. ACG Case Rep J. 2017;4:e107. PubMed PMID: 28932754; PubMed Central PMCID: PMCPMC5599691.
98. Donia MS, Cimermancic P, Schulze CJ, et al. A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. Cell. 2014 Sep 11;158(6):1402–1414. PubMed PMID: 25215495; PubMed Central PMCID: PMCPMC4164201.
99. Cohen LJ, Esterhazy D, Kim SH, et al. Commensal bacteria make GPCR ligands that mimic human signalling molecules. Nature. 2017 Sep 7;549(7670):48–53. PubMed PMID: 28854168.
100. Lee SH. Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases. Intest Res. 2015 Jan;13(1):11–18. PubMed PMID: 25691839; PubMed Central PMCID: PMCPMC4316216.
101. Bueno L, Fioramonti J. Protease-activated receptor 2 and gut permeability: a review. Neurogastroenterol Motil. 2008 Jun;20(6):580–587. PubMed PMID: 18482083.
102. Enjoji S, Ohama T, Sato K. Regulation of epithelial cell tight junctions by protease-activated receptor 2. J Vet Med Sci. 2014 Sep;76(9):1225–1229. PubMed PMID: 24881651; PubMed Central PMCID: PMCPMC4197149.
103. Sturniolo GC, Di Leo V, Ferronato A, et al. Zinc supplementation tightens “leaky gut” in crohn’s disease. Inflamm Bowel Dis. 2001 May;7(2):94–98. PubMed PMID: 11383597.
104. Rosenkranz E, Maywald M, Hilgers RD, et al. Induction of regulatory T cells in Th1-/Th17-driven experimental autoimmune encephalomyelitis by zinc administration. J Nutr Biochem. 2016 Mar;29:116–123. PubMed PMID: 26895672.
105. Rao R, Samak G. Role of glutamine in protection of intestinal epithelial tight junctions. J Epithel Biol Pharmacol. 2012 Jan;5(Suppl 1–M7):47–54. PubMed PMID: 25810794; PubMed Central PMCID: PMCPMC4369670.